Qube Research & Technologies (QRT)
TEVA icon

Qube Research & Technologies (QRT)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$118M Buy
+2,976,366
New +$106M 0.1% 244
2026
Q2 		– Sell
-59,306
Closed -$1.98M – 4072
2026
Q1 		$1.79M Buy
+59,306
New +$1.91M ﹤0.01% 2239
2025
Q2 		– Sell
-2,933,131
Closed -$47.3M – 3968
2025
Q1 		$45.1M Buy
2,933,131
+1,580,349
+117% +$28.2M 0.05% 440
2024
Q4 		$29.8M Buy
1,352,782
+126,145
+10% +$2.29M 0.04% 552
2024
Q3 		$22.1M Sell
1,226,637
-857,362
-41% -$15M 0.03% 629
2024
Q2 		$33.9M Buy
2,083,999
+2,022,219
+3,273% +$31.1M 0.05% 418
2024
Q1 		$872K Buy
+61,780
New +$779K ﹤0.01% 2229
2023
Q3 		– Sell
-1,618,232
Closed -$12.2M – 4332
2023
Q2 		$12.2M Buy
1,618,232
+226,841
+16% +$1.84M 0.04% 483
2023
Q1 		$12.3M Buy
+1,391,391
New +$13.8M 0.05% 406
2022
Q4 		– Sell
-2,216,584
Closed -$17.9M – 2991
2022
Q3 		$17.9M Buy
2,216,584
+1,933,334
+683% +$17.1M 0.11% 260
2022
Q2 		$2.13M Buy
+283,250
New +$2.47M 0.02% 781
2021
Q3 		– Sell
-348,175
Closed -$3.45M – 2763
2021
Q2 		$3.45M Buy
+348,175
New +$3.69M 0.04% 525
2020
Q4 		– Sell
-60,196
Closed -$542K – 2193
2020
Q3 		$542K Sell
60,196
-116,487
-66% -$1.23M 0.01% 1001
2020
Q2 		$2.18M Buy
+176,683
New +$2M 0.03% 633

Other funds holding TEVA

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TEVA Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026: 2,976,366 shares worth $118M. The stake represents 0.1% of the portfolio and ranks #244 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in TEVA as recently as Q1 2026.

Qube Research & Technologies (QRT) first reported a position in TEVA in Q2 2020 and has held it in 14 quarters since. 477 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Qube Research & Technologies (QRT) held 2,976,366 shares of Teva Pharmaceutical Industries Limited worth $118M as of Q3 2026.
  • Teva Pharmaceutical Industries Limited was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Teva Pharmaceutical Industries Limited made up 0.1% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #244 holding.
  • Qube Research & Technologies (QRT) first reported a position in Teva Pharmaceutical Industries Limited in Q2 2020 and has held it in 14 quarters since.
  • 477 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.